NPM1 and neoplasm: For instance, mutations associated with favorable prognosis, such as NPM1 mutations, are typically linked to immune activation and enhanced anti-tumor responses (5), while mutations associated with poor prognosis, such as TP53 mutations, often lead to immune suppression or escape, impairing immune surveillance (6).